Literature DB >> 8619988

Kinetics of PAPS translocase: evidence for an antiport mechanism.

J D Ozeran1, J Westley, N B Schwartz.   

Abstract

In order to gain an understanding of the mechanisms involved in the transfer of 3'-phosphoadenosine 5'-phosphosulfate (PAPS) from the cytosol where it is synthesized to the Golgi lumen where it serves as the universal sulfate donor for sulfate ester formation in higher organisms, we have undertaken a kinetic characterization of the PAPS translocase from rat liver Golgi. Analyzing the PAS translocase activity in both intact Golgi vesicles and in a reconstituted liposome system, we have determined a number of physical and kinetic parameters. Strong competitive inhibition in zero-trans uptake experiments only with beta-methylene PAPS and adenosine 3',5'-biphosphate (PAP) suggest the transporter is highly specific for the 3'-phosphate. The demonstration of trans acceleration as observed by stimulation of transport activity under exchange conditions suggests that the translocase is a carrier with distinct binding sites accessible from both faces of the membrane. The behavior of the PAPS translocase in the presence of equilibrium concentrations of PAP supports the function of an antiport mechanism. Thus the translocase is characterized by its kinetic properties as a specific transporter of PAPS which acts through an antiport mechanism with PAP as the returning ligand. This characterization of the transport activity has proved instrumental in the identification of an approximate 230 kDa Golgi membrane protein as the PAPS translocase protein [Ozeran, J.D., Westley, J., & Schwartz, N.B. (1996) Biochemistry 35, 3695-3703 (accompanying paper)].

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8619988     DOI: 10.1021/bi951302u

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  4 in total

1.  Two Golgi-resident 3'-Phosphoadenosine 5'-phosphosulfate transporters play distinct roles in heparan sulfate modifications and embryonic and larval development in Caenorhabditis elegans.

Authors:  Katsufumi Dejima; Daisuke Murata; Souhei Mizuguchi; Kazuko H Nomura; Tomomi Izumikawa; Hiroshi Kitagawa; Keiko Gengyo-Ando; Sawako Yoshina; Tomomi Ichimiya; Shoko Nishihara; Shohei Mitani; Kazuya Nomura
Journal:  J Biol Chem       Date:  2010-06-06       Impact factor: 5.157

2.  Inhibition of Lithium-Sensitive Phosphatase BPNT-1 Causes Selective Neuronal Dysfunction in C. elegans.

Authors:  Joshua D Meisel; Dennis H Kim
Journal:  Curr Biol       Date:  2016-07-07       Impact factor: 10.834

3.  A role for a lithium-inhibited Golgi nucleotidase in skeletal development and sulfation.

Authors:  Joshua P Frederick; A Tsahai Tafari; Sheue-Mei Wu; Louis C Megosh; Shean-Tai Chiou; Ryan P Irving; John D York
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-11       Impact factor: 11.205

Review 4.  Sulfonation, an underexploited area: from skeletal development to infectious diseases and cancer.

Authors:  Ada W. Y. Leung; Ian Backstrom; Marcel B Bally
Journal:  Oncotarget       Date:  2016-08-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.